We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+9.06%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.65B
AUM Growth
+$213M
Cap. Flow
+$127M
Cap. Flow %
7.68%
Top 10 Hldgs %
13.99%
Holding
1,616
New
434
Increased
384
Reduced
359
Closed
375

Top Buys

Rank Stock Value
1
ESTC icon
Elastic
ESTC
+$6.65M
2
K
Kellanova
K
+$6.45M
3
CORZ icon
Core Scientific
CORZ
+$5.85M
4
BITO icon
ProShares Bitcoin Strategy ETF
BITO
+$5.79M
5
GTM
ZoomInfo Technologies
GTM
+$5.61M

Top Sells

Rank Stock Value
1
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$11.1M
2
WDC icon
Western Digital
WDC
+$8.43M
3
HLIT icon
Harmonic Inc
HLIT
+$7.72M
4
NTES icon
NetEase
NTES
+$7.33M
5
FTRE icon
Fortrea Holdings
FTRE
+$6.96M

Sector Composition

Rank Sector Weight
1 Technology 14.94%
2 Consumer Discretionary 9.59%
3 Healthcare 9.5%
4 Industrials 8.56%
5 Communication Services 6.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HBIO icon
1226
Harvard Bioscience
HBIO
$29.1M
$35.3K ﹤0.01%
1,311
-712
-35% -$21K
ORMP icon
1227
Oramed Pharmaceuticals
ORMP
$175M
$35.2K ﹤0.01%
+14,435
New +$35.2K
PRPL icon
1228
Purple Innovation
PRPL
$41.5M
$34.5K ﹤0.01%
+1,396
New +$40.3K
DNMR
1229
DELISTED
Danimer Scientific, Inc.
DNMR
$32.5K ﹤0.01%
1,792
-2,670
-60% -$46.6K
MGX icon
1230
Metagenomi Therapeutics
MGX
$46.3M
$30.5K ﹤0.01%
+14,074
New +$48.8K
HYPD
1231
Hyperion DeFi Inc
HYPD
$40M
$29.7K ﹤0.01%
+719
New +$46.3K
RAPT
1232
DELISTED
RAPT Therapeutics
RAPT
$28.9K ﹤0.01%
1,800
+437
+32% +$8.84K
PACB icon
1233
Pacific Biosciences
PACB
$360M
$28.6K ﹤0.01%
16,800
-2,286
-12% -$3.76K
RMNI icon
1234
Rimini Street
RMNI
$465M
$21.7K ﹤0.01%
11,712
– –
ALLK
1235
DELISTED
Allakos
ALLK
$16.3K ﹤0.01%
25,000
– –
IRD
1236
Opus Genetics
IRD
$307M
$15.9K ﹤0.01%
12,110
-1,742
-13% -$2.68K
ELEV
1237
DELISTED
Elevation Oncology
ELEV
$7.34K ﹤0.01%
12,240
-79,754
-87% -$118K
PSNYW icon
1238
Polestar Automotive Holding ADS Class C-1
PSNYW
$388M
$4.96K ﹤0.01%
551
– –
LONA
1239
LeonaBio Inc
LONA
$72M
$4.91K ﹤0.01%
1,100
-694
-39% -$16.3K
SRZNW icon
1240
Surrozen Inc Warrant
SRZNW
$8.86K
$254 ﹤0.01%
24,614
– –
KPLTW
1241
DELISTED
Katapult Holdings Warrant
KPLTW
$163 ﹤0.01%
28,680
– –
ABCL icon
1242
AbCellera Biologics
ABCL
$2.82B
– –
-120,900
Closed -$358K
ABR icon
1243
PUT
Arbor Realty Trust
ABR
$978M
– –
-27,100
Closed -$389K
ABSI icon
1244
Absci
ABSI
$1.53B
– –
-15,500
Closed -$47.7K
ACEL icon
1245
Accel Entertainment
ACEL
$973M
– –
-10,235
Closed -$105K
ACN icon
1246
Accenture
ACN
$109B
– –
-1,071
Closed -$325K
ACWI icon
1247
iShares MSCI ACWI ETF
ACWI
$33.3B
– –
-2,220
Closed -$250K
ADP icon
1248
Automatic Data Processing
ADP
$108B
– –
-1,467
Closed -$350K
ADT icon
1249
ADT
ADT
$5.51B
– –
-196,020
Closed -$1.49M
ADTN icon
1250
Adtran
ADTN
$655M
– –
-13,469
Closed -$70.8K
48 49
50
51 52

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, Prelude Capital Management held 1,616 positions worth $1.65B, up 15% from $1.44B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Prelude Capital Management deployed $127M of net new capital in Q3 2024, opening 434 new positions and adding to 384 existing holdings. Its largest new stake was Kellanova: 90,625 shares worth $7.31M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Western Digital, an estimated $8.43M trimmed.

  • Prelude Capital Management's largest Q3 2024 buy was Kellanova: 90,625 shares worth $7.31M.
  • Prelude Capital Management added most to Elastic in Q3 2024, an estimated $6.65M increase.
  • Prelude Capital Management's biggest Q3 2024 reduction was Western Digital, cutting an estimated $8.43M.
  • Prelude Capital Management fully exited Cerevel Therapeutics Holdings, Inc. Common Stock in Q3 2024, selling an estimated $11.1M.
  • Prelude Capital Management's ten largest holdings make up 14% of its $1.65B portfolio in Q3 2024.
  • Prelude Capital Management opened 434 new positions and closed 375 in Q3 2024.
  • Prelude Capital Management's portfolio value rose 15% quarter-over-quarter to $1.65B.

Based on Prelude Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.